A peptide containing a relatively small number of amino acids.
| Member | Definition | Role |
|---|
| (3S,6S,9S,12R)-3-[(2S)-Butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone | | (3S,6S,9S,12R)-3-[(2S)-Butan-2-yl]-6-[(1-methoxyindol-3-yl)methyl]-9-(6-oxooctyl)-1,4,7,10-tetrazabicyclo[10.4.0]hexadecane-2,5,8,11-tetrone |
| 3-fluoro-Nalpha-(1H-indol-2-ylcarbonyl)-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-phenylalaninamide | A secondary carboxamide resulting from the formal condensation of the carboxy group of 1H-indole-2-carboxylic acid with the primary amino group of 3-fluoro-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-phenylalaninamide. It is an inhibitor of SARS coronavirus main proteinase and inhibits SARS-CoV-2 replication in cell culture (EC50 = 0.72 muM). | 3-fluoro-Nalpha-(1H-indol-2-ylcarbonyl)-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-phenylalaninamide |
| alanyl-glutamyl-aspartic acid | | Ala-Glu-Asp |
| alanyl-glycyl-glycine | | Ala-Gly-Gly |
| amogastrin | | Amogastrin |
| angiotensin amide | | angiotensinamide |
| apelin-12 peptide | A 12 amino acid oligopeptide fragment of apelin-13 lacking the terminal L-phenylalanine residue. | apelin-12 |
| apelin-13 peptide | A 13 amino acid oligopeptide which is the ligand for the apelin receptor (also known as the APJ receptor). It exhibits hypotensive and neuroprotective effects, and may be a potential prognostic biomarker for acute ischemic stroke and multiple sclerosis. | apelin-13 |
| arg-3-hyp-7-phe-bradykinin | A ten-membered oligopeptide comprising D-arginyl, L-arginyl, L-prolyl, (4R)-4-hydroxy-L-prolyl, glycyl, L-phenylalanyl, L-seryl, D-phenylalanyl, L-phenylalanyl and L-arginine residues joined in sequence. | NPC-567 |
| arginyl-glycyl-aspartic acid | | Arg-Gly-Asp |
| arginyl-glycyl-glutamic acid | | Arg-Gly-Glu |
| arginyl-glycyl-serine | | Arg-Gly-Ser |
| atosiban | | atosiban |
| bms-650032 | | asunaprevir |
| bradykinin | A linear nonapeptide messenger belonging to the kinin group of proteins, with amino acid sequence RPPGFSPFR. Enzymatically produced from kallidin in the blood, it is a powerful vasodilator that causes smooth muscle contraction, and may mediate inflammation. | bradykinin |
| bradykinin, des-arg(9)- | An eight-membered oligopeptide comprising Arg, Pro, Pro, Gly, Phe, Ser, Pro and Phe residues joined in sequence. It is an analogue of bradykinin lacking the Arg residue at position 9. | [des-Arg(9)]-bradykinin |
| bradykinin, des-phe(8)-des-arg(9)- | A seven-membered oligopeptide comprising Arg, Pro, Pro, Gly, Phe, Ser, and Pro residues joined in sequence by peptide bonds. It is a metabolite of bradykinin lacking the Phe residue at position 8 and the Arg residue at position 9. | [des-Phe(8), des-Arg(9)]-bradykinin |
| bradykinin, hydroxy-pro(3)- | An oligopeptide that is an analogue of bradykinin in which the third amino acid, proline, is replaced with hydroxyproline. | [Hyp(3)]-bradykinin |
| bremelanotide | | bremelanotide |
| buserelin | | buserelin |
| cadystin protein, s pombe | A phytochelatin that is a heptapeptide consisting of 3 units of gamma-Glu-Cys, with a glycyl unit at the C-terminus. | phytochelatin 3 |
| callipeltin a | A 10-membered cyclodepsipeptide containing four amino acids in the L- configuration, Ala, Leu, Thr (2 residues); one (Arg) in the D-configuration; two N-methyl amino acids, N-MeAla and N-MeGln; a methoxy tyrosine, a 3, 4-dimethyl-L-glutamine, and a 4-amino-7-guanidino-2,3 dihydroxypentanoic acid (AGDHE), formally derived from L-Arg. It is obtained from the shallow water sponge Callipelta and has been found to show activity against HIV virus. | callipeltin A |
| ceruletide | A decapeptide comprising 5-oxoprolyl, glutamyl, aspartyl, O-sulfotyrosyl, threonyl, glycyl, tryptopyl, methionyl, aspartyl and phenylalaninamide residues in sequence. Found in the skins of certain Australian amphibians, it is an analogue of the gastrointestinal peptide hormone cholecystokinin and stimulates gastric, biliary, and pancreatic secretion. It is used in cases of paralysis of the intestine (paralytic ileus) and as a diagnostic aid in pancreatic malfunction. | ceruletide |
| cetrorelix | A synthetic ten-membered oligopeptide comprising N-acetyl-3-(naphthalen-2-yl)-D-alanyl, 4-chloro-D-phenylalanyl, 3-(pyridin-3-yl)-D-alanyl, L-seryl, L-tyrosyl, N(5)-carbamoyl-D-ornithyl, L-leucyl, L-arginyl, L-prolyl, and D-alaninamide residues coupled in sequence. A gonadotrophin-releasing hormone (GnRH) antagonist, it is used for treatment of infertility and of hormone-sensitive cancers of the prostate and breast. | cetrorelix |
| cgp 42112a | A hexapeptide consisting of L-tyrosine, L-lysine, L-histidine, L-proline and L-isoleucine amino acid residues coupled in sequence and in which the amino group of the L-tyrosyl residue is substituted by a (pyridin-3-ylcarbonyl)nitrilo group and in which the L-lysyl side chain amino group is substituted by a {N(2)-[(benzyloxy)carbonyl]-L-arginyl}nitrilo group. It is a potent angiotensin II receptor type 2 (AT2 receptor) agonist. | CGP-42112A |
| cilengitide | | cilengitide |
| cyclo(d-tyrosyl-arginyl-arginyl-3-(2-naphthyl)alanyl-glycyl) | | Cyclo[3-(2-naphthalenyl)-l-alanylglycyl-d-tyrosyl-l-arginyl-l-arginyl] |
| davunetide | | davunetide |
| dermorphin | | Dermorphin |
| deslorelin | | Deslorelin |
| diglycyl-histidine | | Gly-Gly-His |
| diprotin b | | Val-Pro-Leu |
| elastin | | N-Acetyl-L-leucyl-L-isoleucylglycyl-L-valyl-N-methyl-L-prolinamide |
| endomorphin 1 | | L-Phenylalaninamide, L-tyrosyl-L-prolyl-L-tryptophyl- |
| enkephalin, ser(2), leu(5), thr(6)- | | DSLET |
| fertirelin | | fertirelin |
| gamma-glutamylfelinylglycine | | Gamma-Glutamylfelinylglycine |
| glycyl-alanyl-phenylalanine | | Gly-Ala-Phe |
| glycyl-glycyl-cysteine | | Gly-Gly-Cys |
| glycyl-glycyl-valine | | Gly-Gly-Val |
| glycyl-histidyl-glycine | | Gly-His-Gly |
| glycyl-leucyl-phenylalanine | | Gly-Leu-Phe |
| glycyl-leucyl-tyrosine | | Gly-Leu-Tyr |
| glycyl-prolyl-arginine | | Gly-Pro-Arg |
| glycyl-prolyl-glutamic acid | | Gly-Pro-Glu |
| glycyl-prolyl-hydroxyproline | | Glycylprolylhydroxyproline |
| gonadotropin-releasing hormone | A ten-membered synthetic oligopeptide comprising pyroglutamyl, histidyl, tryptophyl, seryl, tyrosyl, glycyl, leucyl, arginyl, prolyl and glycinamide residues joined in sequence. | gonadorelin |
| goralatide | | Ac-Ser-Asp-Lys-Pro-OH; goralatide |
| hemorphin 4 | | Hemorphin-4 |
| histrelin | An oligopeptide comprising pyroglutamyl, histidyl, tryptophyl, seryl, tyrosyl, 1-benzyl-D-histidyl, leucyl, arginyl, and N-ethylprolinamide residues joined in sequence. It is a synthetic nonapeptide analogue of gonadotropin-releasing hormone, and is used as a subcutaneous hydrogel implant (particularly as the diacetate salt) for the treatment of prostate cancer and for the suppression of gonadal sex hormone production in children with central precocious puberty. | histrelin |
| icatibant | A ten-membered synthetic oligopeptide consisting of D-Arg, Arg, Pro, Hyp, Gly, Thi, Ser, D-Tic, Oic, and Arg residues joined in sequrence. A bradykinin receptor antagonist used as its acetate salt for the treatment of acute attacks of hereditary angioedema in adult patients. | icatibant |
| isoleucyl-prolyl-proline | | Ile-Pro-Pro |
| isoleucyl-valyl-tyrosine | | Ile-Val-Tyr |
| kentsin | | Kentsin |
| kinetensin | An oligopeptide comprising of nine amino acids with sequence L-Ile-L-Ala-L-Arg-L-Arg-L-His-L-Pro-L-Tyr-L-Phe-L-Leu. It was originally isolated from pepsin-treated human plasma and shares some sequence homology with the C-terminal end of neurotensin. It is a potent histamine releaser and may serve as an inflammatory mediator. | kinetensin |
| l796778 | A methyl ester resulting from the formal condensation of the carboxy group of N-{[(2S)-1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl}-D-norleucyl-L-lysine with methanol. It is a partial agonist of somatostatin subtype receptor 3 (Ki = 24 nM) that exhibits anticonvulsant effects. | L-796,778 |
| leucyl-aspartyl-valine | | Leu-Asp-Val |
| leucyl-prolyl-proline | | Leu-Pro-Pro |
| leuprolide | An oligopeptide comprising pyroglutamyl, histidyl, tryptophyl, seryl, tyrosyl, D-leucyl, leucyl, arginyl, and N-ethylprolinamide residues joined in sequence. It is a synthetic nonapeptide analogue of gonadotropin-releasing hormone, and is used as a subcutaneous hydrogel implant (particularly as the acetate salt) for the treatment of prostate cancer and for the suppression of gonadal sex hormone production in children with central precocious puberty. | leuprolide |
| lysyl-glutamyl-aspartic acid | | Lys-Glu-Asp |
| lysyl-tryptophyl-alpha-lysine | | Lys-Trp-Lys |
| lysyl-tyrosyl-lysine | | Lys-Tyr-Lys |
| methionyl-leucyl-phenylalanine | | Met-Leu-Phe |
| montirelin | | Montirelin |
| morphiceptin | | Morphiceptin |
| msh (11-13) | | Lys-Pro-Val |
| msh release-inhibiting hormone | | Melanostatin |
| N-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamide | A secondary carboxamide resulting from the formal condensation of the carboxy group of 1H-indole-2-carboxylic acid with the primary amino group of 3-cyclohexyl-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide. It is an inhibitor of SARS coronavirus main proteinase and inhibits SARS-CoV-2 replication in cell culture (EC50 = 0.53 muM). | N-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamide |
| nafarelin | An oligopeptide comprising of 5-oxo-L-proline, L-histidine, L-tryptophan, L-serine, L-tyrosine, 3-(2-naphthyl)-D-alanine, L-leucine, L-arginine and L-prolylglycinamide residues joined sequence by peptide linkages. It is a gonadotropin releasing hormone agonist that is used to treat central precocious puberty in children and endometriosis in women. | nafarelin |
| p 829 | | depreotide |
| pentigide | | pentigetide |
| phakellistatin 13 | | Phakellistatin 13 |
| phenylalanyl-phenylalanyl-glycine | | Phe-Phe-Gly |
| phenylalanyl-phenylalanyl-phenylalanine | | Phe-Phe-Phe |
| phenylalanyl-prolyl-arginine | | Phe-Pro-Arg |
| phomopsin | | Phomopsin A |
| posatirelin | | posatirelin |
| prolyl-glycyl-glycine | | Pro-Gly-Gly |
| prolyl-leucyl-glycine | | Pro-Leu-Gly |
| prolyl-prolyl-glycine | | Pro-Pro-Gly |
| pyroglutamyl-glutamyl-proline amide | | Pglu-glu-pro-amide |
| rgh 0205 | | Arg-Lys-Asp |
| rhizonin a | | Rhizonin A |
| rigin | | Rigin |
| s-(2-chloroethyl)glutathione | | S-(2-Chloroethyl)glutathione |
| s-benzoylmercaptoacetyltriglycine | | betiatide |
| s-ethyl glutathione | | Glutathione ethyl ester |
| saralasin | | saralasin |
| seryl-lysyl-leucine | | Ser-Lys-Leu |
| sincalide | | sincalide |
| spinorphin | | Spinorphin |
| splenopentin | | Arg-Lys-Glu-Val-Tyr |
| splenotritin | | Arg-Lys-Glu |
| ta 0910 | An oligopeptide comprising of (4S)-1-methyl-2,6-dioxohexahydropyrimidine-4-carboxylic acid, L-histidine and L-prolinamide joined in sequence by peptide linkages. It is a thyrotropin-releasing hormone (TRH) analog. Its tetrahydrate form is approved in Japan for the treatment of spinal muscular atrophy. | taltirelin |
| teicoplanin aglycone | | teicoplanin aglycone |
| telaprevir | An oligopeptide consisting of N-(pyrazin-2-ylcarbonyl)cyclohexylalanyl, 3-methylvalyl, octahydrocyclopenta[c]pyrrole-1-carboxy, and 3-amino-N-cyclopropyl-2-oxohexanamide residues joined in sequence. Used for treatment of chronic hepatitis C virus genotype 1 infection. | telaprevir |
| thymopentin | | thymopentin |
| trimethionine | | Met-Met-Met |
| ulimorelin | | Ulimorelin |
| ustiloxin d | | Ustiloxin D |